Navigation Links
New Foam Treatment for Varicose Veins
Date:3/18/2008

Study says it passed safety tests and is relatively painless

TUESDAY, March 18 (HealthDay News) -- A new foam for treatment of varicose veins proved safe in patients, according to the results of a Phase II clinical trial.

The trial found that use of injectable Varisolve microfoam didn't cause any neurological, visual or cardiac changes in a small group of patients with a common heart defect.

Since 1997, injectable sclerosant foams have been a standard treatment for spider veins and small varicose veins. These foams are typically made by mixing a sclerosant -- an irritant that causes damage to the vein wall and subsequent scarring -- with room air. Varisolve is made with carbon dioxide and is relatively painless compared to other sclerosants, which can cause burning, according to Dr. John D. Regan, clinical director of the interventional section in the department of radiology at Wake Forest University Baptist Medical Center.

Regan was expected to present the study's findings March 18 in Washington, D.C., at the annual scientific meeting of the Society of Interventional Radiology. The study was funded by BTG International, which makes Varisolve.

The 28 patients studied so far had right-to-left shunt in their hearts. This common, usually asymptomatic heart defect affects about one-quarter of the population. In people with this defect, there's an increased risk that bubbles from injectable foams to treat varicose veins will cross the shunt and go to the brain or heart without being filtered in the lungs, Regan said.

While tiny bubbles were detected in the blood of 90 percent of the 28 patients treated with Varisolve, there were no signs of neurological, visual or cardiac changes during monitoring using ultrasound, MRI and other methods. The study will continue until 50 patients have been treated and monitored.

More information

The U.S. National Women's Health Information Center has more about varicose veins.



-- Robert Preidt



SOURCE: Wake Forest University Baptist Medical Center, news release, March 17, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants
2. Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists
3. Researchers study new drug and indications for heated chemotherapy treatment
4. Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining
5. Damaged veins heal faster with heparin treatment, laboratory study finds
6. Current and Emerging Therapies Have No Advantage Over Pfizers Lyrica in Their Effect on Patients Quality of Life in the Treatment of Diabetic Neuropathy
7. Novel discovery by Einstein scientists could lead to much-needed kidney failure treatment
8. Scripps Florida awarded $7.6 million grant to develop novel treatment for Parkinsons disease
9. More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
10. New potential treatment for muscular dystrophy appears to be safe
11. Leading researchers honored for progress in cancer prevention, detection and treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Foam Treatment for Varicose Veins
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... edition of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic ... health while maintaining fulfilling lives. “We are prolonging life 6 years in the ...
(Date:12/2/2016)... ... 2016 , ... Sourced from the Isbre Springs beneath the 5,000 year old ... purity of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent ... in several ShopRite and FoodTown stores in NJ and received rave comments from consumers. ...
(Date:12/2/2016)... San Francisco, CA (PRWEB) , ... December 02, ... ... in digitally-enabled care journeys, announced today that it has raised $6.0 million in ... are inspired by Clarify Health’s conviction that patients and their caregivers can receive ...
(Date:12/2/2016)... ... 2016 , ... ‘Tis the season for giving! Today, 20 creative teams across ... Partnership and the Drug Enforcement Administration as part of the National Red Ribbon Week ... schools who decorated their campuses with this year’s Red Ribbon Week theme: “YOLO. Be ...
(Date:11/30/2016)... ... 30, 2016 , ... Standard Process, Inc. is proud to ... recognition of the largest closely held companies headquartered in Wisconsin. This marks the ... Standard Process was awarded the Talent Award for providing outstanding employee benefits. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... 2, 2016 On Thursday, December ... excellence in research, development and innovation in the biopharmaceutical ... was held in the presence of Sergey Tsyb, Vice ... Russian Federation , Natalia Sanina, First Vice Chairman ... , Head of Roszdravnadzor, National Service of Control in ...
(Date:12/2/2016)... -- bioLytical Laboratories, ein Weltführer bei schnellen Tests für Infektionskrankheiten, ... von Kenia eingeführt. Continue Reading ... ... (PRNewsFoto/bioLytical Laboratories) ... http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical wurde durch die Clinton ...
Breaking Medicine Technology: